← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Augusta University Research Institute, Inc
$26,264,573
Total funding
41
Grants
Funding over time
peak $5.8M · FY2008–22$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
DOD$23,993,958 · 38
DOE$1,520,615 · 2
NASA$750,000 · 1
By mechanism
—$26,264,573 · 41
Investigators at Augusta University Research Institute, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
DEVELOPMENT OF A NOVEL SOLUBLE EPOXIDE HYDROLASE INHIBITOR AS A STRATEGY FOR TREATING NEUROPATHIC PAIN IN PATIENTS WITH SPINAL CORD INJURY$3,434,971
· FY2021 · Defense Health Agency
NEW AWARD; TITLE: LINKS BETWEEN PERSISTENT DNA DAMAGE, GENOME INSTABILITY, AND AGING; PI: WILLIAM DYNAN$1,520,632
· FY2009 · Department of Energy
EXOSOME THERAPY FOR STABILIZATION OF EXTREMITY INJURY$1,270,988
· FY2018 · Defense Health Agency
SENSITIZING PROSTATE CANCER TO FERROPTOSIS-BASED THERAPY$1,155,000
· FY2022 · Defense Health Agency
GULF WAR WOMEN'S HEALTH COHORT$1,138,877
· FY2016 · Department of the Army
HOXC9-INDUCED DIFFERENTIATION IN NEUROBLASTOMA DEVELOPMENT$1,123,083
· FY2012 · Department of the Army
MODULATION OF HEMOSTASIS AND METABOLIC HOMEOSTASIS TO TREAT HEMORRHAGIC SHOCK$993,366
· FY2022 · Defense Health Agency
METABOLIC TARGETING OF SKP2 EXPRESSION AS A NOVEL THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER$920,250
· FY2019 · Department of the Army
NOVEL THERAPEUTIC STRATEGY FOR THE PREVENTION OF BONE FRACTURES$913,688
· FY2010 · Department of Defense
ONCOLYTIC VIRAL THERAPY FOR BREAST CANCER$885,453
· FY2021 · Defense Health Agency
ORGANOPHOSPHATE-RELATED ALTERATIONS IN MYELIN AND AXONAL TRANSPORT IN THE LIVING MAMMALIAN BRAIN$859,673
· FY2012 · Department of Defense
NEURAL CORRELATES OF RECOGNIZING CAMOUFLAGED OBJECTS: A HUMAN FMRI AND EEG STUDY$841,171
· FY2015 · Department of the Army
MITOCHONDRIA-TARGETED THERAPY FOR GULF WAR ILLNESS$770,000
· FY2021 · Defense Health Agency
IMPLICATIONS OF MENTAL HEALTH ILLNESS ON OUTCOMES OF PROSTATE CANCER PATIENTS IN THE VETERANS AFFAIRS MEDICAL SYSTEM.$765,615
· FY2020 · Defense Health Agency
THE SKELETON S ABILITY TO ADAPT TO MECHANICAL LOADING IS CRUCIAL FOR BONE HEALTH AS EXERCISE PROMOTES HYPERTROPHY BUT DISUSE (SUCH AS FROM SPACEFLIGHT) LEADS TO BONE LOSS. WE WERE THE FIRST TO REPORT THAT SMALL TRANSIENT PLASMA MEMBRANE DISRUPTIONS$750,000
· FY2021 · National Aeronautics and Space Administration
MYOSTATIN INHIBITORS TO ACCELERATE TISSUE REGENERATION$713,489
· FY2009 · Department of Defense
ROLE OF ADENOSINE RECEPTOR A2A IN TRAUMATIC OPTIC NEUROPATHIES$688,465
· FY2011 · Department of Defense
MICRORNA DETERMINANTS OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER$649,993
· FY2018 · Defense Health Agency
CHARACTERIZING MYELOID CELL ACTIVATION IN NF1 VASCULOPATHY$607,643
· FY2015 · Department of the Army
DEVELOPMENT OF NOVEL NONINVASIVE TESTS FOR PROGNOSTIC PREDICTIONS FOR BLADDER CANCER$606,947
· FY2018 · Defense Health Agency